Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies

Abstract Introduction Cancer diagnosis influences the choices that patients make regarding current and future labor market activity. These choices have implications for governments based on resulting changes in taxes paid and benefits received. In this analysis we explore how human growth receptor 2...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Svenn Alexander Kommandantvold, Nikos Kotsopoulos, Isabel Monteiro, Ana Ladeiras, Andrew Hogan, Felipe Barboza Magalhães de Araujo, Mark P. Connolly
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Adis, Springer Healthcare 2024-02-01
Saila:	Oncology and Therapy
Gaiak:	Fiscal analysis Cost–benefit analysis HER2-positive breast cancer Life course modeling Cancer survival
Sarrera elektronikoa:	https://doi.org/10.1007/s40487-024-00264-9
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!